Cannabis Law Report

JANUARY 29, 2020

In 2019, California cannabis consumers continued to learn about and turn to cannabis to address their various needs. To provide a picture of California’s legal cannabis marketplace, we’ve aggregated our proprietary data to illustrate the behavior of over half a million cannabis consumers who purchased via the Eaze platform in 2019.

Vaping 59

Vaping Edibles Topical Concentrates 59

Cannabis Law Report

NOVEMBER 19, 2019

MEDFORD, OREGON – November 18, 2019 — Grown Rogue International Inc. Over 50 dispensary owners and/or managers were surveyed during a two-week timeframe between September 17, 2019 and October 4, 2019. As a public company, Grown Rogue is always analyzing market conditions to ensure capital expenditures drive ROI.

Data 45

Data Dispensary Retail Recreational 45

Cannabis Law Report

FEBRUARY 4, 2019

Winter Edition 2019 – Cannabis. 2019 Legislative Session – Agency Proposed Legislation. Leaf Data Systems Update. On January 9, 2019 the Board approved a motion to make the effective date for all marijuana product, packaging and labeling requirements Jan 1, 2020. Here’s the Table of Contents.

Topical 65

Topical Packaging Retail Legislation 65

Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For many other people of all ages, tinnitus is indeed a chronic condition that has nothing to do with loud ‘80s cover bands in small clubs. And it’s not just ringing. A review of the current literature.” And its conclusion?

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

NOVEMBER 26, 2019

Planet 13 Announces Third Quarter 2019 Financial Results Press Release | 11/25/2019. Planet 13 Announces Third Quarter 2019 Financial Results. million for the nine months ended September 30, 2019. of all Nevada cannabis dispensary revenue in Q3 2019 1. million , 24% sequential growth over Q2 2019.

Data 59

Data Dispensary Edibles Conditions 59

The Blunt Truth

JUNE 13, 2019

In New Mexico, lawmakers have added opioid addiction to the list of conditions allowing the use of medical marijuana. Let’s not make any predictions until all the data is in. While it’s unlikely that any action will result in 2019, 2020 may be a big year in that regard. in 17 states.

CBD 40

CBD Food Topical Data 40

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

JANUARY 31, 2019

January 31, 2019. Portland, OR — Today the Oregon Liquor Control Commission provided the Oregon Legislative Assembly with the 2019 Recreational Marijuana Supply and Demand Legislative Report required by ORS 475B.548. 2019 Recreational Marijuana Supply and Demand Legislative Report. Here’s the statement in full.

Legislation 61

Legislation Recreational Marijuana Policy 61

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 105

Consumption Patients Research and Development Data 105

The Cannigma

JUNE 30, 2021

In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% The most common medical conditions. In Colorado, 78.7%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Law Report

JUNE 23, 2021

In 2019, the island’s economy grew by 2.1% RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens,” said Gregory Wagner , CEO of RYAH Group, Inc. in real terms to £4.97 billion, servicing nearly 340,000 active patients. .

Programs 100

Programs Data Events Collective 100

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

CannaMD

DECEMBER 8, 2020

In 2019, that trend finally appeared to shift as the FBI’s Uniform Crime Report tallied 545,601 marijuana arrests compared to 663,367 in 2018 and 659,700 in 2017. The cannabis total from 2019 represents 35% of all drug related arrests. Alarmingly, 92% of those arrests were for simple possession only. Sentencing Commission.

Marijuana 105

Marijuana Chronic Pain Treatment Legalization 105

SpeedWeed

JANUARY 25, 2019

Phil Murphy (D) on Wednesday announced that opioid addiction will be added to the list of qualifying conditions that allows residents to obtain medical marijuana, reports NJ.com. — Governor Phil Murphy (@GovMurphy) January 23, 2019. 20, averaging nearly 7 deaths per day. 20, averaging nearly 7 deaths per day.

Treatment 65

Treatment Marijuana Conditions Data 65

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. 1) The severity of the condition can vary widely.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

DECEMBER 9, 2019

That said, research conducted to date has been promising, with CBD demonstrating the potential for aiding with a wide range of health conditions and resulting symptoms. Like humans, pets also feel anxiety, pain, and suffer from chronic conditions such as arthritis. Anxiety and Inflammation Lead the Pack.

Pets 59

Pets CBD Research and Development Epilepsy 59

Cannabis Law Report

AUGUST 3, 2021

Hemp Benchmarks , a division of New Leaf Data Services and leading provider of financial, business, and industry data for the North American hemp markets, recently issued its report for July, which touches on some of the most high-profile talking points of the hemp market to date.

Hemp 105

Hemp Data CBD THC 105

Cannabis Law Report

MAY 21, 2022

At the end of 2019, in an interview published on Observador.pt , Eurico Castro Alves, former president of Infarmed (Autoridade Nacional do Medicamento e Produtos de Saúde) had stated that, within a few years, cannabis would soon become one of the protagonists of the Portuguese GDP. Here are all the details.

Decriminalization 52

Decriminalization Cultivation Data Cannabis 52

Veriheal

MARCH 29, 2023

The Relationship Between Marijuana Use and Psychosis Using the Optum Clinformatics DataMart Database , which functions as an anonymous Medicare Advantage and commercial claims database, scientists were able to gather data with unprecedented precision. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2

Legalization 57

Legalization Data Policy Cannabis 57

Veriheal

JULY 12, 2021

As a veteran, being able to get past the PTSD involves transitioning out of the mental and emotional war zone, which is challenging and the reason why veterans seek out multiple methods to deal with the condition. A study conducted by Miriam Reisman reported that between 13.5% What Is The Latest Research for Veterans and PTSD?

Treatment 104

Treatment Sleep Clinical Trials Data 104

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

NOVEMBER 13, 2019

Introducing the 2 nd Annual Hemp & CBD Industry Factbook – the most comprehensive and reliable data resource for the hemp and CBD industry available today and the only report to deliver a complete, end-to-end look at the cannabis supply chain. Here’s the full blurb and link to buy.

Hemp 45

Hemp Supply Chain CBD Data 45

The Cannigma

DECEMBER 20, 2021

terpenes ) may help treat a number of different skin conditions. Some of these have been identified as possible targets for the treatment of inflammatory skin conditions. Can cannabis make inflammatory skin conditions worse? Skin inflammation conditions are just as complex and involve an array of cells and molecules.

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. Related story Can CBD Help Your Condition? CBD for hypertension. Preclinical promise.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

The Cannigma

FEBRUARY 24, 2022

As of 2019, about 200 million people used cannabis worldwide, and there are nearly 8 billion people on earth. This isn’t at all specific to humans – data have shown a variety of responses to cannabis across other vertebrates. Is cannabis essential for good health? Clinical endocannabinoid deficiency.

Cannabinoids 128

Cannabinoids Research and Development Conditions Cannabis 128

CannaMD

NOVEMBER 22, 2020

For those who suffer from migraine pain, the excruciating condition can be completely debilitating, impossible to manage without a dark room, a cool cloth over the eyes, and sublime silence. Patients used the app, Strainprint, which allowed data to be archived and studied. and migraine severity by 49.6%.

Marijuana 116

Marijuana Treatment Patients Cannabinoids 116

Veriheal

NOVEMBER 18, 2022

In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined.

Edibles 86

Edibles Hemp Epilepsy Programs 86

The Joint Blog

DECEMBER 20, 2020

“Respondents reported a median score of 90 on a zero to 100-point scale in response to the question, “How does cannabis affect your conditions or symptoms overall?” Materials and Methods: A cross-sectional online survey of those using cannabis for health-related conditions run between May and July 2019.

Sleep 49

Sleep Data Pharmaceutical Marijuana 49

Cannabis Law Report

JUNE 9, 2021

According to the report, retail cannabis sales grew 21% between 2019 and 2020 and grew 605% between 2015 and 2020. The report, which analyzed the cannabis industry in 2020, gathered data from a number of sources to generate its findings. Effect Of Legalized Recreational Home Grow.

Legalization 105

Legalization Recreational Data Retail 105

SpeedWeed

AUGUST 31, 2021

6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. Meanwhile, 17,492 patients with non-defined chronic medical conditions were the second most common. Psychiatric disorders accounted for 11,914 patients.

Programs 72

Programs Patients Dispensary Cultivation 72

Kind Meds (Cannabis Education Blog)

MARCH 9, 2022

In some states, it is still illegal to use marijuana recreationally; however, you can get a medical card if you have an approved condition. This can be a great tool for parents who suffer from conditions like chronic pain, anxiety, and depression. [3] Cannabis use, employment, and income: fixed-effects analysis of panel data.

Digestion 98

Digestion Consumption Cannabis Recreational 98

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. A 2019 study found that 76% of patients in the U.S. Expanded Qualifying Conditions. Findings from the CDC’s 2019 National Health Interview Survey report that 20.4%

Programs 52

Programs Chronic Pain Treatment Conditions 52

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. Related story Can CBD Help Your Condition? CBD for hypertension. Preclinical promise.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

The Cannigma

AUGUST 24, 2021

Google announced in May, 2019 that they had updated their policy section of the Google to ban apps “that facilitate the sale of marijuana or maijruan products, regardless of legality.” As co-founder Otha Smith said, “through data, we aim to empower not only cannabis consumers, but the entire industry.”.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Veriheal

JUNE 19, 2023

All the data provided by the report are validated and trustworthy and can be used to gain the upper hand in the industry. Food & Drug Administration in 2019 when it was found to work for patients who were unresponsive to other treatments. Why Is the Psychedelics Market Growing?

Therapy 105

Therapy Treatment Patients Policy 105

Cannabis Law Report

OCTOBER 15, 2019

As United Nations (UN) member states are set to meet in March 2019 to take stock of progress made since 2009 and delineate the next phase for global drug policy, this report evaluates the impacts of drug policies in Asia over the past decade from a civil society perspective. Copyright: International Drug Policy Consortium Publication 2019.

Policy 40

Policy Data Consumption Conditions 40

The Blunt Truth

SEPTEMBER 17, 2019

On September 10, 2019, the Federal Trade Commission (FTC) sent warning letters to three companies that sold cannabidiol (CBD) products marketed with misleading claims that they could treat serious diseases. In 2019, the FDA issued four warning letters, and publicly disclosed the names of the companies in question.

CBD 77

CBD Food Tincture Compliance 77